|
|
News Breaks | | | | August 3, 2012 | | 11:31 EDT |  | MNTA, WPI | Momenta loses appeals court ruling over Lovenox copy, Bloomberg reports
Momenta (MNTA) has lost an appeals court ruling over Watson's (WPI) Lovebox copy, Bloomberg reports. Amphastar, Watson's partner, can continue selling the copy, the court rules. | |
|
News For MNTA;WPI From The Last 14 Days Check below for free stories on MNTA;WPI the last two weeks. |
|
|
| June 17, 2013 | | 07:25 EDT |  | MNTA | Leerink to host a conference
 Subscribe for More Information | | | June 6, 2013 | | 10:01 EDT |  | MNTA | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | | 07:00 EDT | | MNTA | Momenta Pharma upgraded to Buy from Neutral at UBS
UBS upgraded Momenta (MNTA) based on increased confidence for generic Copaxone approval in time for a September 2015 launch when the patents expire and potentially earlier, in the event of a favorable appeals court decision vs. Teva (TEVA). Price target raised to $17 from $13. | |
|
|
|
|
|
|
